Document is current
Any future updates will be listed below
-
Authors
Andreano, Emanuele https://orcid.org/0000-0003-0088-5788
Paciello, Ida
Piccini, Giulia https://orcid.org/0000-0001-8090-7910
Manganaro, Noemi https://orcid.org/0000-0001-8512-4704
Pileri, Piero https://orcid.org/0000-0002-2888-8748
Hyseni, Inesa
Leonardi, Margherita
Pantano, Elisa
Abbiento, Valentina
Benincasa, Linda
Giglioli, Ginevra
De Santi, Concetta
Fabbiani, Massimiliano
Rancan, Ilaria
Tumbarello, Mario
Montagnani, Francesca
Sala, Claudia
Montomoli, Emanuele
Rappuoli, Rino https://orcid.org/0000-0002-8827-254X
- License Information
-
More Information
Article History
Received: 19 August 2021
Accepted: 8 October 2021
First Online: 20 October 2021
Competing interests
: R.R. is an employee of the GSK group of companies. E.A., I.P., N.M., P.P., E.P., C.D.S., C.S. and R.R. are listed as inventors of full-length human mAbs described in Italian patent applications no. 102020000015754 filed on 30 June 2020, 102020000018955 filed on 3 August 2020 and 102020000029969 filed on 4 December 2020, and the international patent system number PCT/IB2021/055755 filed on 28 June 2021. All patents were submitted by Fondazione Toscana Life Sciences, Siena, Italy. The remaining authors declare no competing interests.
